Corrigendum to “Tanshinone IIA Alleviates CCL2-Induced Leaning memory and Cognition Impairment in Rats: A Potential Therapeutic Approach for HIV-Associated Neurocognitive Disorder”

---

Following the publication of the article “Tanshinone IIA Alleviates CCL2-Induced Leaning memory and Cognition Impairment in Rats: A Potential Therapeutic Approach for HIV-Associated Neurocognitive Disorder” [1], the authors identified that the incorrect images were presented in Figures 8(d) and 8(g). Figure 8(g) was mistakenly duplicated with Figure 8(f), and Figure 8(d) was incorrectly taken from a different experiment. The authors explained that the error occurred during manuscript preparation and apologize for any inconvenience caused. The correct figure is as follows

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 8 

Cell apoptosis of hippocampal tissues in rats among the seven groups. (a–g) Representative 400× images of the TUNEL staining. TUNEL staining showed that Tan IIA reduced CCL2-induced cell apoptosis in the hippocampus CA1 areas, and the brown nuclei represented TUNEL-positive cells. (h) Cell apoptosis rate among seven groups. The results are expressed as , . versus the model group (Tan IIA(L): 25 mg/kg, Tan IIA(M): 50 mg/kg; Tan IIA(H): 75 mg/kg). (a) Control. (b) Sham. (c) Model. (d) Memantine. (e) Tan IIA(L). (f) Tan IIA(M). (g) Tan IIA(H).